Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Connect Biopharma Holdings (CNTB) Change in Accured Expenses (2024 - 2025)

Historic Change in Accured Expenses for Connect Biopharma Holdings (CNTB) over the last 2 years, with Q3 2025 value amounting to $999000.0.

  • Connect Biopharma Holdings' Change in Accured Expenses rose 131829.27% to $999000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $114000.0, marking a year-over-year change of. This contributed to the annual value of -$1.7 million for FY2024, which is 7240.87% up from last year.
  • According to the latest figures from Q3 2025, Connect Biopharma Holdings' Change in Accured Expenses is $999000.0, which was up 131829.27% from $695000.0 recorded in Q2 2025.
  • Over the past 5 years, Connect Biopharma Holdings' Change in Accured Expenses peaked at $999000.0 during Q3 2025, and registered a low of -$1.3 million during Q2 2024.